Dr. Karslioglu-French`s research interests are: 1) Inpatient Hyperglycemia Management, 2)Thyroid Molecular Markers, and 3)Innovative Models of Health Care Delivery
Dr. Karslioglu-French is co-chair of diabetes patient safety committee where she develops systemwide diabetes management protocols and works on diabetes quality improvement projects with fellows.
Her second clinical interest is thyroid disease. She performs ultrasound guided thyroid biopsies in thyroid clinic. She provides care for thyroid eye disease patients in collaboration with ophthalmologists and endocrine surgeons.
- MD, Hacettepe Universitesi, Turkey, 2001
- MBA, Executive MBA in Healthcare, University of Pittsburgh Katz School of Business, 2020
- Residency, Internal Medicine, University of Pittsburgh Medical Center Shadyside, 2007
- Clinical Fellowship, Endocrinology, Diabetes and Metabolism, University of Pittsburgh, 2009
- Research Fellowship, Endocrinology, Diabetes and Metabolism, University of Pittsburgh, 2011
Education & Training
Yip, L., Gooding, W. E., Nikitski, A., Wald, A. I., Carty, S. E., Karslioglu-French, E., Seethala, R. R., Zandberg, D. P., Ferris, R. L., Nikiforova, M. N., Nikoforov, Y. E. Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study. Cancer. 2021; Online Ahead of Print.
Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 2019; 365: I1114.
Puri S, Roy N, Russ H, Leonhardt L, Karslioglu French E, Roy R, Bengtsson H, Scott D, Stewart AF, Hebrok M. Replication confers ß cell immaturity. Nature Communications. 2018; 9(1): 485.
Korytkowski, M.T., Karslioglu, E., Brooks, M., Kanter, J., Lombardero, M., Magaji, V., Orchard, T., Siminerio, L. Use of an Electronic Medical Record to Identify Prevalent and Incident Cardiovascular Disease in Type 2 Diabetes According to Treatment Strategy. BMJ Open Diabetes Research & Care. 2016; 4(1)
Karslioglu, E., Kleinberger, J., Salim, F., Cox, A., Takane, K.K., Scott, D.K., Stewart, A.F. cMyc is the principal upstream driver of beta cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta cell replication. Journal of Molecular Endocrinology. 2011; 25: 1760-72.
Korytkowski MT, Salata RJ, Koerbel GL, Selzer F, Karslioglu E, Idriss AM, Lee KK, Moser AJ, Toledo FG. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009; 32(4): 594-6.
Noschese M, Donihi AC, Koerbel G, Karslioglu E, Dinardo M, Curll M, Korytkowski MT. Effect of a diabetes order set on glycemic management and control in the hospital. Qual Saf Health Care. 2008; 17(6): 464-8.
